亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

7-Azaindenoisoquinolines as Anticancer Agents

总结
Researchers at Purdue University have developed a series of 7-azaindenoisoquinoline derivatives that act to inhibit topoisomerase and subsequently induce cell death. This new class of topoisomerase inhibitors has the potential to possess enhanced chemical stability over traditional inhibitors, while increasing inhibitor effectiveness.
技术优势
Azaindenoisoquinolines have enhanced chemical stability and effectiveness over other TOP1 inhibitorsTOP1 is a proven target for cancer therapy
技术应用
Cancer TreatmentMedical/HealthcarePharmaceuticals
详细技术说明
Mark CushmanPurdue Medicinal Chemistry and Molecular Pharmacology
*Abstract

*Background
Topoisomerase 1 (TOP1) is an important protein found in the cell; it is used to unwind and reduce torsional stress on DNA during replication. TOP1 inhibitors are a useful chemotherapy agent because cells that are constantly dividing, such as cancer cells, are much more susceptible to attack; cell death will occur when topoisomerase 1 is inhibited. TOP1 inhibitors make up a large portion of the chemotherapy market because they can be used to target a wide variety of proliferating tumors. The characteristic of uninhibited division is a common feature in cancer that can be targeted without needing a specific marker for each cancer cell type. As more information becomes readily available, it is becoming apparent that within tumors there is a heterogeneous population of cells populating the primary tumor and the secondary tumors.
*IP Issue Date
Apr 1, 2014
*IP Type
Utility
*Stage of Development
Proof of Concept
*Web Links
Purdue Office of Technology CommercializationPurdueInnovation and EntrepreneurshipMark CushmanPurdue Medicinal Chemistry and Molecular Pharmacology
国家
United States
申请号码
8,686,146
国家/地区
美国

欲了解更多信息,请点击 这里
移动设备